{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:04:40Z","timestamp":1790784280911,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100006419","name":"EuroQol Research Foundation","doi-asserted-by":"publisher","award":["1992-RA"],"award-info":[{"award-number":["1992-RA"]}],"id":[{"id":"10.13039\/501100006419","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"DOI":"10.1007\/s40273-026-01658-5","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:17:48Z","timestamp":1790781468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Justifying and Classifying Adults\u2019 Roles in Child Health State Valuation: A Novel Taxonomy"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8784-9650","authenticated-orcid":false,"given":"Stefan A.","family":"Lipman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian T.","family":"Reckers-Droog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Rowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"1658_CR1","volume-title":"Methods for the economic evaluation of health care programmes","author":"MF Drummond","year":"2015","unstructured":"Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2015."},{"key":"1658_CR2","volume-title":"Oxford research encyclopedia of economics and finance","author":"JL Pinto-Prades","year":"2019","unstructured":"Pinto-Prades JL, Attema A, S\u00e1nchez-Mart\u00ednez FI. Measuring health utility in economics. In: Oxford research encyclopedia of economics and finance. 2019."},{"key":"1658_CR3","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s10198-020-01195-8","volume":"21","author":"M Kennedy-Martin","year":"2020","unstructured":"Kennedy-Martin M, Slaap B, Herdman M, van Reenen M, Kennedy-Martin T, Greiner W, et al. Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. Eur J Health Econ. 2020;21:1245\u201357.","journal-title":"Eur J Health Econ"},{"issue":"4","key":"1658_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jval.2025.12.016","volume":"29","author":"LS Matza","year":"2026","unstructured":"Matza LS, Rowen D, Chandler F, Dalziel K, Ghabri S, Law EH, et al. Valuing child and adolescent health states for use in economic evaluation: a Good Practices Report of an ISPOR Task Force. Value Health. 2026;29(4):535\u201346.","journal-title":"Value Health."},{"issue":"7","key":"1658_CR5","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s11136-019-02121-z","volume":"28","author":"J Kwon","year":"2019","unstructured":"Kwon J, Kim SW, Ungar WJ, Tsiplova K, Madan J, Petrou S. Patterns, trends and methodological associations in the measurement and valuation of childhood health utilities. Qual Life Res. 2019;28(7):1705\u201324.","journal-title":"Qual Life Res"},{"issue":"2","key":"1658_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s40273-021-01107-5","volume":"40","author":"C Bailey","year":"2022","unstructured":"Bailey C, Dalziel K, Cronin P, Devlin N, Viney R, Team QOLiKKEtSDiAP. How are child-specific utility instruments used in decision making in Australia? A review of pharmaceutical benefits advisory committee public summary documents. Pharmacoeconomics. 2022;40(2):157\u201382.","journal-title":"Pharmacoeconomics"},{"key":"1658_CR7","unstructured":"Zorginstituut Nederland. Guideline for economic evaluations in healthcare: Zorginstituut Nederland. https:\/\/english.zorginstituutnederland.nl\/publications\/reports\/2024\/01\/16\/guideline-for-economic-evaluations-in-healthcare. Accessed Sep 2024."},{"issue":"7","key":"1658_CR8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jval.2020.02.011","volume":"23","author":"H Hill","year":"2020","unstructured":"Hill H, Rowen D, Pennington B, Wong R, Wailoo A. A review of the methods used to generate utility values in NICE technology assessments for children and adolescents. Value Health. 2020;23(7):907\u201317.","journal-title":"Value Health"},{"issue":"4","key":"1658_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s40273-021-01128-0","volume":"40","author":"J Kwon","year":"2022","unstructured":"Kwon J, Freijser L, Huynh E, Howell M, Chen G, Khan K, et al. Systematic review of conceptual, age, measurement and valuation considerations for generic multidimensional childhood patient-reported outcome measures. Pharmacoeconomics. 2022;40(4):379\u2013431.","journal-title":"Pharmacoeconomics"},{"issue":"10","key":"1658_CR10","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jval.2018.03.016","volume":"21","author":"D Rowen","year":"2018","unstructured":"Rowen D, Mulhern B, Stevens K, Vermaire JH. Estimating a Dutch value set for the pediatric preference-based CHU9D using a discrete choice experiment with duration. Value Health. 2018;21(10):1234\u201342.","journal-title":"Value Health"},{"issue":"Suppl. 2","key":"1658_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s40273-022-01192-0","volume":"40","author":"B Roudijk","year":"2022","unstructured":"Roudijk B, Sajjad A, Essers B, Lipman S, Stalmeier P, Finch AP. A value set for the EQ-5D-Y-3L in the Netherlands. Pharmacoeconomics. 2022;40(Suppl. 2):193\u2013203.","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"1658_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00005650-200202000-00006","volume":"40","author":"D Feeny","year":"2002","unstructured":"Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002;40(2):113\u201328.","journal-title":"Med Care"},{"issue":"7","key":"1658_CR13","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40273-020-00909-3","volume":"38","author":"JM Ramos-Go\u00f1i","year":"2020","unstructured":"Ramos-Go\u00f1i JM, Oppe M, Stolk E, Shah K, Kreimeier S, Rivero-Arias O, et al. International valuation protocol for the EQ-5D-Y-3L. Pharmacoeconomics. 2020;38(7):653\u201363.","journal-title":"Pharmacoeconomics"},{"issue":"Suppl. 2","key":"1658_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s40273-022-01190-2","volume":"40","author":"F Rencz","year":"2022","unstructured":"Rencz F, Ruzsa G, Bat\u00f3 A, Yang Z, Finch AP, Brodszky V. Value set for the EQ-5D-Y-3L in Hungary. Pharmacoeconomics. 2022;40(Suppl. 2):205\u201315.","journal-title":"Pharmacoeconomics"},{"issue":"Suppl. 2","key":"1658_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40273-022-01216-9","volume":"40","author":"Z Yang","year":"2022","unstructured":"Yang Z, Jiang J, Wang P, Jin X, Wu J, Fang Y, et al. Estimating an EQ-5D-Y-3L value set for China. Pharmacoeconomics. 2022;40(Suppl. 2):147\u201355.","journal-title":"Pharmacoeconomics"},{"issue":"Suppl. 2","key":"1658_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40273-022-01187-x","volume":"40","author":"S Dewilde","year":"2022","unstructured":"Dewilde S, Roudijk B, Tollenaar NH, Ramos-Go\u00f1i JM. An EQ-5D-Y-3L value set for Belgium. Pharmacoeconomics. 2022;40(Suppl. 2):169\u201380.","journal-title":"Pharmacoeconomics"},{"issue":"8","key":"1658_CR17","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/hec.775","volume":"12","author":"S Petrou","year":"2003","unstructured":"Petrou S. Methodological issues raised by preference\u2010based approaches to measuring the health status of children. Health Econ. 2003;12(8):697\u2013702.","journal-title":"Health Econ"},{"key":"1658_CR18","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2165\/11591570-000000000-00000","volume":"29","author":"WJ Ungar","year":"2011","unstructured":"Ungar WJ. Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated? Pharmacoeconomics. 2011;29:641\u201352.","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"1658_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s40273-019-00873-7","volume":"38","author":"D Rowen","year":"2020","unstructured":"Rowen D, Rivero-Arias O, Devlin N, Ratcliffe J. Review of valuation methods of preference-based measures of health for economic evaluation in child and adolescent populations: where are we now and where are we going? Pharmacoeconomics. 2020;38(4):325\u201340.","journal-title":"Pharmacoeconomics"},{"issue":"7","key":"1658_CR20","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.jval.2021.01.011","volume":"24","author":"SA Lipman","year":"2021","unstructured":"Lipman SA, Reckers-Droog VT, Kreimeier S. Think of the children: a discussion of the rationale for and implications of the perspective used for EQ-5D-Y health state valuation. Value Health. 2021;24(7):976\u201382.","journal-title":"Value Health"},{"issue":"7","key":"1658_CR21","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jval.2022.05.009","volume":"25","author":"NJ Devlin","year":"2022","unstructured":"Devlin NJ. Valuing child health isn\u2019t child\u2019s play. Value Health. 2022;25(7):1087\u20139.","journal-title":"Value Health."},{"issue":"1","key":"1658_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-022-01998-8","volume":"20","author":"N Devlin","year":"2022","unstructured":"Devlin N, Pan T, Kreimeier S, Verstraete J, Stolk E, Rand K, et al. Valuing EQ-5D-Y: the current state of play. Health Qual Life Outcomes. 2022;20(1):1\u201311.","journal-title":"Health Qual Life Outcomes"},{"key":"1658_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10198-025-01823-1","volume":"27","author":"AF Hoogenboom","year":"2025","unstructured":"Hoogenboom AF, Reckers-Droog VT, Lipman SA, Brouwer W. Nothing about us, without us? A reflection on and call for involving children in the process of valuing child health. Eur J Health Econ. 2025;27:355\u201362.","journal-title":"Eur J Health Econ"},{"issue":"Suppl. 2","key":"1658_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s40273-022-01222-x","volume":"40","author":"JL Nazari","year":"2022","unstructured":"Nazari JL, Pickard AS, Gu NY. Findings from a roundtable discussion with US stakeholders on valuation of the EQ-5D-Y-3L. Pharmacoeconomics. 2022;40(Suppl. 2):139\u201346.","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"1658_CR25","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s11136-024-03618-y","volume":"33","author":"F Xie","year":"2024","unstructured":"Xie F, Xie S, Pullenayegum E, Ohinmaa A. Understanding Canadian stakeholders\u2019 views on measuring and valuing health for children and adolescents: a qualitative study. Qual Life Res. 2024;33(5):1415\u201322.","journal-title":"Qual Life Res"},{"issue":"1","key":"1658_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12955-025-02397-5","volume":"23","author":"M Malik","year":"2025","unstructured":"Malik M, Hussain A, Purba FD, Gu NY. Findings from a roundtable discussion with Pakistani stakeholders on measuring and valuing health and health-related quality of life for children and adolescents. Health Qual Life Outcomes. 2025;23(1):65.","journal-title":"Health Qual Life Outcomes"},{"key":"1658_CR27","unstructured":"Rivero-Arias O, Campbell H, Rowen D, Mott D, Shah K. Estimating an EQ-5D-Y-3L value set in the United Kingdom: a stakeholder-informed protocol for a health valuation study. EuroQol Plenary Paper. 2025."},{"key":"1658_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2024.117127","volume":"355","author":"PA Powell","year":"2024","unstructured":"Powell PA, Rowen D, Keetharuth A, Mukuria C, Shah K. Who should value children\u2019s health and how? An international Delphi study. Soc Sci Med. 2024;355:117127.","journal-title":"Soc Sci Med"},{"issue":"5","key":"1658_CR29","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1177\/0272989X21999607","volume":"41","author":"DJ Mott","year":"2021","unstructured":"Mott DJ, Shah KK, Ramos-Go\u00f1i JM, Devlin NJ, Rivero-Arias O. Valuing EQ-5D-Y-3L health states using a discrete choice experiment: do adult and adolescent preferences differ? Med Decis Making. 2021;41(5):584\u201396.","journal-title":"Med Decis Making"},{"key":"1658_CR30","doi-asserted-by":"crossref","unstructured":"Sullivan T, Wyeth EH, Turner RM, Hansen P, Ombler F, Devlin NJ, Derrett S. Can adolescents value the EQ-5D-Y-5L and EQ-5D-5L, and how do the values compare? A feasibility study. Value in Health, 2025;28(6):936\u201344.","DOI":"10.1016\/j.jval.2025.02.013"},{"issue":"5","key":"1658_CR31","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.jval.2025.01.020","volume":"28","author":"JL Nazari","year":"2025","unstructured":"Nazari JL, Ramos-Go\u00f1i JM, Gu NY, Pickard AS. An acquired taste: latent class analysis to compare adolescent and adult preferences for EQ-5D-Y-3L health states. Value Health. 2025;28(5):781\u20139.","journal-title":"Value Health"},{"key":"1658_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2165\/11536960-000000000-00000","volume":"9","author":"J Ratcliffe","year":"2011","unstructured":"Ratcliffe J, Couzner L, Flynn T, Sawyer M, Stevens K, Brazier J, et al. Valuing Child Health Utility 9D health states with a young adolescent sample: a feasibility study to compare best-worst scaling discrete-choice experiment, standard gamble and time trade-off methods. Appl Health Econ Health Policy. 2011;9:15\u201327.","journal-title":"Appl Health Econ Health Policy"},{"key":"1658_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2026.119193","volume":"398","author":"A Yu","year":"2026","unstructured":"Yu A, Luo Y, Bahranpour M, Norman R, Street D, Viney R, et al. Understanding how adults and adolescents value children\u2019s health states: a qualitative exploration using discrete choice experiments (DCEs) with and without duration. Soc Sci Med. 2026;398:119193.","journal-title":"Soc Sci Med"},{"key":"1658_CR34","doi-asserted-by":"crossref","unstructured":"Pan T, Ramos-Goni JM, Roudijk B, Xie S, Xie F, Yang Z, et al. Testing the valuation of the EQ-5D-Y-5L in adults and adolescents: results from a five-country study and implications for the descriptive system. Value Health. 2025.","DOI":"10.1016\/j.jval.2025.07.016"},{"issue":"11","key":"1658_CR35","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s40273-025-01530-y","volume":"43","author":"S Xie","year":"2025","unstructured":"Xie S, Pan T, Ramos-Goni JM, Mulhern B, Yang Z, Norman R, et al. Eliciting and anchoring health state preferences using discrete choice experiments among adults, adolescents, and children. Pharmacoeconomics. 2025;43(11):1353\u201366.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"1658_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s40271-023-00649-4","volume":"17","author":"JA van Til","year":"2024","unstructured":"van Til JA, Pearce A, Ozdemir S, Hollin IL, Peay HL, Wu AW, et al. Role preferences in medical decision making: relevance and implications for health preference research. Patient Patient-Centered Outcomes Res. 2024;17(1):3\u201312.","journal-title":"Patient Patient-Centered Outcomes Res"},{"issue":"5","key":"1658_CR37","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s40273-022-01133-x","volume":"40","author":"D Rowen","year":"2022","unstructured":"Rowen D, Mukuria C, Powell PA, Wailoo A. Exploring the issues of valuing child and adolescent health states using a mixed sample of adolescents and adults. Pharmacoeconomics. 2022;40(5):479\u201388.","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"1658_CR38","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/0272989X9901900416","volume":"19","author":"P Dolan","year":"1999","unstructured":"Dolan P. Whose preferences count. Med Decis Making. 1999;19(4):482\u20136.","journal-title":"Med Decis Making"},{"key":"1658_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780192632531.001.0001","volume-title":"Distributing health care: economic and ethical issues","author":"P Dolan","year":"2002","unstructured":"Dolan P, Olsen JA. Distributing health care: economic and ethical issues. Oxford: Oxford University Press; 2002."},{"issue":"7","key":"1658_CR40","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jval.2021.11.1377","volume":"25","author":"S Dewilde","year":"2022","unstructured":"Dewilde S, Janssen MF, Lloyd AJ, Shah KK. Exploration of the reasons why health state valuation differs for children compared to adults: a mixed methods approach. Value Health. 2022;25(7):1185\u201395.","journal-title":"Value Health."},{"key":"1658_CR41","unstructured":"Powell PA, \u00c5str\u00f6m M, Berg J, Burstrom K, Carlton J, Henriksson M, et al. Whose opinion matters when valuing child and adolescent health? Novel insights from surveys of the adult and adolescent public in the UK and Sweden. Data on file, 2024."},{"key":"1658_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2023.116506","volume":"340","author":"PA Powell","year":"2024","unstructured":"Powell PA, Rowen D, Keetharuth A, Mukuria C. Understanding UK public views on normative decisions made to value health-related quality of life in children: a qualitative study. Soc Sci Med. 2024;340:116506.","journal-title":"Soc Sci Med"},{"key":"1658_CR43","unstructured":"Hoogenboom AF, Mos PPM, Reckers-Droog VT, Lipman SA, van Exel J, Brouwer W. Dutch policymakers\u2019 views on what justifies involving children in health state valuation: a Q-methodology study. Soc Sci Med. 2026."},{"key":"1658_CR44","unstructured":"UK Government. Representation of the People Bill 2026: extending the right to vote to 16 and 17 year olds. 2026; https:\/\/www.gov.uk\/government\/publications\/representation-of-the-people-bill-policy-summaries\/votes-at-16. Accessed 20 Aug 2026."},{"key":"1658_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.appdev.2025.101883","volume":"101","author":"A Lang","year":"2025","unstructured":"Lang A. Adolescent voting competence: can 14-to 17-year-olds vote as well as their parents? J Appl Dev Psychol. 2025;101:101883.","journal-title":"J Appl Dev Psychol"},{"key":"1658_CR46","unstructured":"Rowen D, Keetharuth A, Peasgood T. Generating appropriate and consistent health state utilities and QALYs across the life-course from cradle to grave. Working Paper, 2025."},{"issue":"1","key":"1658_CR47","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/hec.4179","volume":"30","author":"PP Schneider","year":"2021","unstructured":"Schneider PP. Social tariffs and democratic choice: do population\u2010based health state values reflect the will of the people? Health Econ. 2021;30(1):104\u201312.","journal-title":"Health Econ"},{"key":"1658_CR48","unstructured":"Excellence NIfHaC. NICE technology appraisal and highly specialised technologies guidance: the manual. 2025."},{"issue":"7","key":"1658_CR49","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/0277-9536(91)90303-T","volume":"32","author":"DC Hadorn","year":"1991","unstructured":"Hadorn DC. The role of public values in setting health care priorities. Soc Sci Med. 1991;32(7):773\u201381.","journal-title":"Soc Sci Med"},{"issue":"1","key":"1658_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-021-01858-x","volume":"19","author":"PA Powell","year":"2021","unstructured":"Powell PA, Rowen D, Rivero-Arias O, Tsuchiya A, Brazier JE. Valuing child and adolescent health: a qualitative study on different perspectives and priorities taken by the adult general public. Health Qual Life Outcomes. 2021;19(1):1\u201314.","journal-title":"Health Qual Life Outcomes"},{"issue":"7","key":"1658_CR51","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s40273-025-01494-z","volume":"43","author":"X Xiong","year":"2025","unstructured":"Xiong X, Huang L, Carvalho N, Dalziel K, Devlin N. Do the age of children and parental status matter in valuing the Child Health Utility 9D (CHU9D)? Pharmacoeconomics. 2025;43(7):819\u201333.","journal-title":"Pharmacoeconomics"},{"key":"1658_CR52","unstructured":"Trzebi\u0144ski W, Lipman SA, Jakubczyk M. Adults' cTTO valuation of child EQ-5D-Y-3L health states: exploring the role of adult socio-cultural characteristics, valuation perspective, and psychological distance. EsCHER Working Paper Series No. 2025007. Erasmus University Rotterdam. 2025. https:\/\/www.eur.nl\/escher\/research\/workingpapers. Accessed 20 Aug 2025."},{"issue":"Suppl. 2","key":"1658_CR53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40273-022-01202-1","volume":"40","author":"SA Lipman","year":"2022","unstructured":"Lipman SA, Essers BA, Finch AP, Sajjad A, Stalmeier PF, Roudijk B. In a child\u2019s shoes: composite time trade-off valuations for EQ-5D-Y-3L with different proxy perspectives. Pharmacoeconomics. 2022;40(Suppl. 2):181\u201392.","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"1658_CR54","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jval.2025.11.004","volume":"29","author":"Z Lang","year":"2026","unstructured":"Lang Z, Lipman SA, Roudijk B, Stalmeier P, Attema AE. The effect of perspective, duration, and views on death on the valuation of severe health states. Value Health. 2026;29(4):659\u201367.","journal-title":"Value Health"},{"issue":"5","key":"1658_CR55","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/01.mlr.0000160419.27642.a8","volume":"43","author":"AS Pickard","year":"2005","unstructured":"Pickard AS, Knight SJ. Proxy evaluation of health-related quality of life: a conceptual framework for understanding multiple proxy perspectives. Med Care. 2005;43(5):493\u20139.","journal-title":"Med Care"},{"issue":"1","key":"1658_CR56","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1037\/a0038088","volume":"141","author":"IN Defoe","year":"2015","unstructured":"Defoe IN, Dubas JS, Figner B, Van Aken MA. A meta-analysis on age differences in risky decision making: adolescents versus children and adults. Psychol Bull. 2015;141(1):48.","journal-title":"Psychol Bull"},{"key":"1658_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jecp.2023.105691","volume":"233","author":"I Ikink","year":"2023","unstructured":"Ikink I, van Duijvenvoorde AC, Huizenga H, Roelofs K, Figner B. Age differences in intertemporal choice among children, adolescents, and adults. J Exp Child Psychol. 2023;233:105691.","journal-title":"J Exp Child Psychol"},{"issue":"2","key":"1658_CR58","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10198-025-01789-0","volume":"27","author":"N Devlin","year":"2026","unstructured":"Devlin N, Roudijk B, Herdman M, Stolk E, Norman R, Kreimeier S, et al. Valuing health states for infants and toddlers: challenges and methodological considerations in EQ-TIPS preference elicitation. Eur J Health Econ. 2026;27(2):221\u201333.","journal-title":"Eur J Health Econ"},{"issue":"4","key":"1658_CR59","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s41669-021-00270-x","volume":"5","author":"DJ Mott","year":"2021","unstructured":"Mott DJ, Leslie I, Shah K, Rowell J, Scheuer N. Impact of including carer information in time trade-off tasks: results from a pilot study. PharmacoEconomics-Open. 2021;5(4):665\u201375.","journal-title":"PharmacoEconomics-Open"},{"issue":"7","key":"1658_CR60","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.jval.2021.12.014","volume":"25","author":"VT Reckers-Droog","year":"2022","unstructured":"Reckers-Droog VT, Karimi M, Lipman SA, Verstraete J. Why do adults value EQ-5D-Y-3L health states differently for themselves than for children and adolescents: a think-aloud study. Value Health. 2022;25(7):1174\u201384.","journal-title":"Value Health"},{"issue":"1","key":"1658_CR61","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/0272989X14541328","volume":"35","author":"LA Prosser","year":"2015","unstructured":"Prosser LA, Lamarand K, Gebremariam A, Wittenberg E. Measuring family HRQoL spillover effects using direct health utility assessment. Med Decis Making. 2015;35(1):81\u201393.","journal-title":"Med Decis Making"},{"issue":"6","key":"1658_CR62","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s11136-005-5994-6","volume":"15","author":"W Brouwer","year":"2006","unstructured":"Brouwer W, Van Exel N, Van Gorp B, Redekop W. The CarerQol instrument: a new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations. Qual Life Res. 2006;15(6):1005\u201321.","journal-title":"Qual Life Res"},{"issue":"3","key":"1658_CR63","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s40273-023-01321-3","volume":"42","author":"E Henry","year":"2024","unstructured":"Henry E, Al-Janabi H, Brouwer W, Cullinan J, Engel L, Griffin S, et al. Recommendations for emerging good practice and future research in relation to family and caregiver health spillovers in health economic evaluations: a report of the SHEER Task Force. Pharmacoeconomics. 2024;42(3):343\u201362.","journal-title":"Pharmacoeconomics"},{"issue":"8","key":"1658_CR64","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s40273-024-01397-5","volume":"42","author":"R Lamsal","year":"2024","unstructured":"Lamsal R, Yeh EA, Pullenayegum E, Ungar WJ. A systematic review of methods and practice for integrating maternal, fetal, and child health outcomes, and family spillover effects into cost-utility analyses. Pharmacoeconomics. 2024;42(8):843\u201363.","journal-title":"Pharmacoeconomics"},{"key":"1658_CR65","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s10198-020-01205-9","volume":"21","author":"KK Shah","year":"2020","unstructured":"Shah KK, Ramos-Go\u00f1i JM, Kreimeier S, Devlin NJ. An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values. Eur J Health Econ. 2020;21:1091\u2013103.","journal-title":"Eur J Health Econ"},{"key":"1658_CR66","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s40273-026-01589-1","volume":"44","author":"SA Lipman","year":"2026","unstructured":"Lipman SA, Guo Z. EQ-5D(-Y) valuation from adult and child perspectives: where does the empirical evidence leave us and how should we proceed? Pharmacoeconomics. 2026;44:267\u201378.","journal-title":"Pharmacoeconomics"},{"key":"1658_CR67","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10198-019-01155-x","volume":"21","author":"AE Attema","year":"2020","unstructured":"Attema AE, Bleichrodt H, l\u2019Haridon O, Lipman SA. A comparison of individual and collective decision making for standard gamble and time trade-off. Eur J Health Econ. 2020;21:465\u201373.","journal-title":"Eur J Health Econ"},{"issue":"9","key":"1658_CR68","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1016\/j.socscimed.2006.06.016","volume":"63","author":"WJ Ungar","year":"2006","unstructured":"Ungar WJ, Mirabelli C, Cousins M, Boydell KM. A qualitative analysis of a dyad approach to health-related quality of life measurement in children with asthma. Soc Sci Med. 2006;63(9):2354\u201366.","journal-title":"Soc Sci Med"},{"issue":"8","key":"1658_CR69","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2165\/11597890-000000000-00000","volume":"30","author":"WJ Ungar","year":"2012","unstructured":"Ungar WJ, Boydell K, Dell S, Feldman BM, Marshall D, Willan A, et al. A parent-child dyad approach to the assessment of health status and health-related quality of life in children with asthma. Pharmacoeconomics. 2012;30(8):697\u2013712.","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"1658_CR70","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/0272989X9601600204","volume":"16","author":"PF Krabbe","year":"1996","unstructured":"Krabbe PF, Essink-Bot M-L, Bonsel GJ. On the equivalence of collectively and individually collected responses: standard-gamble and time-tradeoff judgments of health states. Med Decis Making. 1996;16(2):120\u201332.","journal-title":"Med Decis Making"},{"issue":"1","key":"1658_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1259-4","volume":"20","author":"S Ozdemir","year":"2019","unstructured":"Ozdemir S, Jafar TH, Choong LHL, Finkelstein EA. Family dynamics in a multi-ethnic Asian society: comparison of elderly CKD patients and their family caregivers experience with medical decision making for managing end stage kidney disease. BMC Nephrol. 2019;20(1):73.","journal-title":"BMC Nephrol"},{"issue":"1","key":"1658_CR72","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2307\/1911842","volume":"56","author":"P-A Chiappori","year":"1988","unstructured":"Chiappori P-A. Rational household labor supply. Econometrica. 1988;56(1):63\u201390.","journal-title":"Econometrica"},{"issue":"7","key":"1658_CR73","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s11136-018-1831-6","volume":"27","author":"JL Wolstenholme","year":"2018","unstructured":"Wolstenholme JL, Bargo D, Wang K, Harnden A, R\u00e4is\u00e4nen U, Abel L. Preference-based measures to obtain health state utility values for use in economic evaluations with child-based populations: a review and UK-based focus group assessment of patient and parent choices. Qual Life Res. 2018;27(7):1769\u201380.","journal-title":"Qual Life Res"},{"issue":"1","key":"1658_CR74","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jval.2018.05.010","volume":"22","author":"E Stolk","year":"2019","unstructured":"Stolk E, Ludwig K, Rand K, van Hout B, Ramos-Go\u00f1i JM. Overview, update, and lessons learned from the international EQ-5D-5L valuation work: version 2 of the EQ-5D-5L valuation protocol. Value Health. 2019;22(1):23\u201330.","journal-title":"Value Health"},{"key":"1658_CR75","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11136-010-9609-5","volume":"19","author":"R Norman","year":"2010","unstructured":"Norman R, King MT, Clarke D, Viney R, Cronin P, Street D. Does mode of administration matter? Comparison of online and face-to-face administration of a time trade-off task. Qual Life Res. 2010;19:499\u2013508.","journal-title":"Qual Life Res"},{"key":"1658_CR76","first-page":"452","volume-title":"Accessing children as research participants: examining the role of gatekeepers","author":"I Coyne","year":"2010","unstructured":"Coyne I. Accessing children as research participants: examining the role of gatekeepers. Oxford: Blackwell Publishing Ltd; 2010. p. 452\u20134."},{"key":"1658_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2025.11.003","author":"AS Pickard","year":"2025","unstructured":"Pickard AS, Nazari JL, Ramos-Go\u00f1i JM, Gu NY. Valuing child health: an EQ-5D-Y-3L value set for the United States. Value Health. 2025.","journal-title":"Value Health"},{"key":"1658_CR78","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s10198-023-01668-6","volume":"25","author":"SA Lipman","year":"2024","unstructured":"Lipman SA, Reckers-Droog VT. Comparing heuristic valuation processes between health state valuation from child and adult perspectives. Eur J Health Econ. 2024;25:1345\u201360.","journal-title":"Eur J Health Econ"},{"key":"1658_CR79","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s40273-024-01415-6","volume":"42","author":"DM Hausman","year":"2024","unstructured":"Hausman DM. Proxy preferences and the values of children\u2019s health states. Pharmacoeconomics. 2024;42:1065\u201372.","journal-title":"Pharmacoeconomics"}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-026-01658-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40273-026-01658-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-026-01658-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:17:51Z","timestamp":1790781471000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40273-026-01658-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":79,"alternative-id":["1658"],"URL":"https:\/\/doi.org\/10.1007\/s40273-026-01658-5","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"value":"1170-7690","type":"print"},{"value":"1179-2027","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Stefan Lipman and Donna Rowen are members of the EuroQol Group. Vivian T. Reckers-Droog and Philip A. Powell have no conflicts of interest that are directly relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflicts of interest\/competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Availability of data and material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Code availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SL conceptualised the paper, obtained funding, developed the first draft of the manuscript and supervised the paper. PP conceptualised the paper, obtained funding, developed the first draft and gave significant feedback. DR and VR conceptualised the paper and provided significant feedback and edits.","order":7,"name":"Ethics","label":"Authors\u2019 contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}